Pfizer Inc. started dosing in a mid-to-late-stage trial of the company’s oral antiviral therapy for Covid-19 in non-hospitalized, symptomatic adult patients.

Pfizer Inc.’s experimental drug to treat patients with moderate-to-severe atopic dermatitis met the main goals of improving symptoms in adult patients compared to a rival treatment from Regeneron Pharmaceutical Inc.

Pfizer Inc. on Aug. 25 said a booster dose of the company’s two-shot Covid-19 vaccine spurs a more than threefold increase in antibodies against the coronavirus, as the drugmaker seeks U.S. regulatory approval for a third injection.

The United States could get Covid-19 under control by early 2022, with potential wider vaccine approvals coming in the weeks ahead, Dr. Anthony Fauci said one day after Pfizer won wider FDA approval for the company’s novel coronavirus shot on Aug. 23.

New York City will require public school teachers and staff to get vaccinated against Covid-19, Mayor Bill de Blasio said on Aug. 23, part of a push to get more residents inoculated and slow the spread of the highly contagious Delta variant.

The U.S. Food and Drug Administration granted the Pfizer-BioNTech Covid-19 vaccine Comirnaty full approval.

Pfizer is buying Toronto and Cambridge, Massachusetts-based Trillium Therapeutics in a deal worth $2.26 billion. Trillium focuses on developing a new set of checkpoint inhibitors to treat cancer.

A third dose of Pfizer’s Covid-19 vaccine significantly improved protection from infection and serious illness among people aged 60 and older in Israel compared with those who received two shots, findings published by the Health Ministry showed on Aug. 22.

The common over-the-counter drug aspirin might be the key to finding a viable treatment method for breast cancer.

The Securities and Exchange Commission (SEC) is charging Matthew Panuwat – a former business development executive at Medivation – with insider trading, according to a complaint filed in court stemming from Pfizer’s acquisition of Medivation in 2016.